English  |  正體中文  |  简体中文  |  2818404  
???header.visitor??? :  28066930    ???header.onlineuser??? :  559
???header.sponsordeclaration???
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
???ui.leftmenu.abouttair???

???ui.leftmenu.bartitle???

???index.news???

???ui.leftmenu.copyrighttitle???

???ui.leftmenu.link???

"liang s k"???jsp.browse.items-by-author.description???

???jsp.browse.items-by-author.back???
???jsp.browse.items-by-author.order1??? ???jsp.browse.items-by-author.order2???

Showing items 41-65 of 137  (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page

Institution Date Title Author
臺大學術典藏 2021-05-18T05:56:44Z Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii) Lee M.-R.; Tsai H.-Y.; Cheng A.; Liu C.-Y.; YU-TSUNG HUANG; Liao C.-H.; Liang S.-K.; Lee L.-N.; Hsueh P.-R.
臺大學術典藏 2021-05-18T05:56:39Z Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000-2014 Lee M.-R.; Tsai C.-J.; Liang S.-K.; Lin C.-K.; YU-TSUNG HUANG; Hsueh P.-R.
臺大學術典藏 2021-05-12T03:27:24Z Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation Keng L.-T.; Chung K.-P.; Lin S.-Y.; Liang S.-K.; Cheng J.-C.; Chen I.-C.; Chen Y.-F.; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; HUEY-DONG WU; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-05-02T04:37:07Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; JANN-YUAN WANG; Ko J.-C.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-05-02T03:49:12Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; JIN-YUAN SHIH; Yu C.-J.
臺大學術典藏 2021-05-02T03:29:21Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; Ko J.-C.; Shih J.-Y.; CHONG-JEN YU
臺大學術典藏 2021-04-29T05:08:49Z Predicting lung cancer occurrence in never-smoking females in Asia: TNSF-SQ, a prediction model Chien L.-H.;Chen C.-H.;Chen T.-Y.;Chang G.-C.;Tsai Y.-H.;Hsiao C.-F.;Kuan-Yu Chen;Su W.-C.;Wang W.-C.;Huang M.-S.;Chen Y.-M.;Chen C.-Y.;Liang S.-K.;Chen C.-Y.;Wang C.-L.;Lee M.-H.;Chung R.-H.;Tsai F.-Y.;Hu J.-W.;Katki H.A.;Chatterjee N.;Chanock S.J.;Rothman N.;Lan Q.;Yang P.-C.;Chen C.-J.;Chang I.-S.;Hsiung C.A.; Chien L.-H.; Chen C.-H.; Chen T.-Y.; Chang G.-C.; Tsai Y.-H.; Hsiao C.-F.; KUAN-YU CHEN; Su W.-C.; Wang W.-C.; Huang M.-S.; Chen Y.-M.; Chen C.-Y.; Liang S.-K.; Chen C.-Y.; Wang C.-L.; Lee M.-H.; Chung R.-H.; Tsai F.-Y.; Hu J.-W.; Katki H.A.; Chatterjee N.; Chanock S.J.; Rothman N.; Lan Q.; Yang P.-C.; Chen C.-J.; Chang I.-S.; Hsiung C.A.
臺大學術典藏 2021-03-13T03:29:27Z Significant clinical factors associated with long-term mortality in critical cancer patients requiring prolonged mechanical ventilation Keng L.-T.;Chung K.-P.;Lin S.-Y.;Liang S.-K.;Cheng J.-C.;Chen I.-C.;Yen-Fu Chen;Chang H.-T.;Hsu C.-L.;Jerng J.-S.;Wang H.-C.;Kuo P.-H.;Wu H.-D.;Shih J.-Y.;Yu C.-J.; Keng L.-T.; Chung K.-P.; Lin S.-Y.; Liang S.-K.; Cheng J.-C.; Chen I.-C.; YEN-FU CHEN; Chang H.-T.; Hsu C.-L.; Jerng J.-S.; Wang H.-C.; Kuo P.-H.; Wu H.-D.; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-12T02:28:37Z Otitis media and otomastoiditis caused by Mycobacterium massiliense (Mycobacterium abscessus subsp. bolletii) Lee M.-R.; Tsai H.-Y.; Cheng A.; Liu C.-Y.; Huang Y.-T.; Liao C.-H.; Liang S.-K.; LI-NA LEE; Hsueh P.-R.
臺大學術典藏 2021-03-12T02:28:34Z Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy Keng L.-T.; Shu C.-C.; Chen J.Y.P.; Liang S.-K.; Lin C.-K.; Chang L.-Y.; Chang C.-H.; Wang J.-Y.; Yu C.-J.; LI-NA LEE
臺大學術典藏 2021-03-11T12:03:52Z Evaluating pleural ADA, ADA2, IFN-γ and IGRA for diagnosing tuberculous pleurisy Keng L.-T.;Shu C.-C.;Chen J.Y.P.;Liang S.-K.;Ching-Kai Lin;Chang L.-Y.;Chang C.-H.;Wang J.-Y.;Yu C.-J.;Lee L.-N.; Keng L.-T.; Shu C.-C.; Chen J.Y.P.; Liang S.-K.; CHING-KAI LIN; Chang L.-Y.; Chang C.-H.; Wang J.-Y.; Yu C.-J.; Lee L.-N.
臺大學術典藏 2021-03-11T12:03:51Z Clinical characteristics of bacteraemia caused by Lactobacillus spp. and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2000-2014 Lee M.-R.; Tsai C.-J.; Liang S.-K.; CHING-KAI LIN; Huang Y.-T.; Hsueh P.-R.
臺大學術典藏 2021-03-11T08:34:25Z Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates Lee M.-R.;Jen-Chang Ko;Liang S.-K.;Lee S.-W.;Yen D.H.-T.;Hsueh P.-R.; MENG-RUI LEE; JEN-CHANG KO; SHENG-KAI LIANG; Lee S.-W.; Yen D.H.-T.; Hsueh P.-R.
臺大學術典藏 2021-03-11T08:34:22Z Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells Pan C.-H.;Chang Y.-F.;Lee M.-S.;Wen B.-C.;Jen-Chang Ko;Liang S.-K.;Liang M.-C.; Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; JEN-CHANG KO; SHENG-KAI LIANG; Liang M.-C.
臺大學術典藏 2021-03-11T08:34:21Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.;Hsieh M.-S.;Lee M.-R.;Keng L.-T.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; Min-Shu Hsieh; MENG-RUI LEE; LI-TA KENG; JEN-CHANG KO; Jin-Yuan Shih
臺大學術典藏 2021-03-11T08:34:19Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.;Lee M.-R.;Liao W.-Y.;Ho C.-C.;Jen-Chang Ko;Shih J.-Y.; SHENG-KAI LIANG; MENG-RUI LEE; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T08:34:18Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Liang S.-K.;Jen-Chang Ko;Yang J.C.-H.;Shih J.-Y.; SHENG-KAI LIANG; JEN-CHANG KO; James Chih-Hsin Yang; Jin-Yuan Shih
臺大學術典藏 2021-03-11T08:29:38Z Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates Lee M.-R.;Jen-Chang Ko;Liang S.-K.;Lee S.-W.;Yen D.H.-T.;Hsueh P.-R.; Lee M.-R.; JEN-CHANG KO; Liang S.-K.; Lee S.-W.; Yen D.H.-T.; Hsueh P.-R.
臺大學術典藏 2021-03-11T08:29:36Z Vorinostat enhances the cisplatin-mediated anticancer effects in small cell lung cancer cells Pan C.-H.; Chang Y.-F.; Lee M.-S.; Wen B.-C.; JEN-CHANG KO; Liang S.-K.; Liang M.-C.
臺大學術典藏 2021-03-11T08:29:35Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T08:29:34Z Prognostic factors of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma: A real-world, large cohort study Liang S.-K.; Lee M.-R.; Liao W.-Y.; Ho C.-C.; JEN-CHANG KO; Shih J.-Y.
臺大學術典藏 2021-03-11T08:29:32Z Afatinib is effective in the treatment of lung adenocarcinoma with uncommon EGFR p.L747P and p.L747S mutations Liang S.-K.; JEN-CHANG KO; Yang J.C.-H.; Shih J.-Y.
臺大學術典藏 2021-03-11T08:29:29Z Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort Liang S.-K.; Keng L.-T.; Chang C.-H.; Wen Y.-F.; Lee M.-R.; Yang C.-Y.; Wang J.-Y.; JEN-CHANG KO; Shih J.-Y.; Yu C.-J.
臺大學術典藏 2021-03-11T07:58:33Z Bacteraemia caused by Mycobacterium abscessus subsp. abscessus and M. abscessus subsp. bolletii: Clinical features and susceptibilities of the isolates Lee M.-R.;Jen-Chang Ko;Liang S.-K.;Lee S.-W.;Yen D.H.-T.;Hsueh P.-R.; Lee M.-R.; JEN-CHANG KO; Liang S.-K.; Lee S.-W.; Yen D.H.-T.; Hsueh P.-R.
臺大學術典藏 2021-03-11T07:58:31Z Real-world experience of afatinib as a first-line therapy for advanced EGFR mutation-positive lung adenocarcinoma Liang S.-K.; Hsieh M.-S.; Lee M.-R.; Keng L.-T.; JEN-CHANG KO; Shih J.-Y.

Showing items 41-65 of 137  (6 Page(s) Totally)
<< < 1 2 3 4 5 6 > >>
View [10|25|50] records per page